Observational studyCancer medicine2025

Overall Survival With Palbociclib and Aromatase Inhibitor Versus Aromatase Inhibitor Alone in Older Patients With HR+/HER2- Metastatic Breast Cancer.

Adam M Brufsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.